222 related articles for article (PubMed ID: 30229824)
1. Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer.
Shi YX; Ye BL; Hu BR; Ruan XJ
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5525-5530. PubMed ID: 30229824
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer.
Zhang Y; Wen X; Hu XL; Cheng LZ; Yu JY; Wei ZB
Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3026-30. PubMed ID: 27460730
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of miR-601 is associated with poor prognosis and tumor progression of gastric cancer.
Min C; Zhang A; Qin J
Diagn Pathol; 2019 Sep; 14(1):107. PubMed ID: 31547835
[TBL] [Abstract][Full Text] [Related]
4. MiR-1298 expression correlates with prognosis and inhibits cell proliferation and invasion of gastric cancer.
Qiu ZK; Liu N; Zhao SF; Ding AP; Cheng G; Qiu WS; Qi WW
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1672-1679. PubMed ID: 29630111
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of miR-1236-3p is correlated with clinical progression and unfavorable prognosis in gastric cancer.
Zhu XP; Wang XL; Ma J; Fang YF; Zhang HJ; Zhang C; Feng MC
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5914-5919. PubMed ID: 30280772
[TBL] [Abstract][Full Text] [Related]
6. The SNORA21 expression is upregulated and acts as a novel independent indicator in human gastric cancer prognosis.
Liu CX; Qiao XJ; Xing ZW; Hou MX
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5519-5524. PubMed ID: 30229823
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of miR-519a Predicts Poor Prognosis and Contributes to Tumor Progression in Gastric Cancer.
Cai H; Lin H; Cao W; Sun J; Huang Y; Fang Y
Oncol Res Treat; 2020; 43(1-2):19-26. PubMed ID: 31743914
[TBL] [Abstract][Full Text] [Related]
8. Up-Regulation of Plasma miR-23b is Associated with Poor Prognosis of Gastric Cancer.
Zhuang K; Han K; Tang H; Yin X; Zhang J; Zhang X; Zhang L
Med Sci Monit; 2016 Feb; 22():356-61. PubMed ID: 26835790
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic significance of miR-4317 expression in gastric cancer patients.
Zhang J; Tian ZL; Zhang WT; Cheng LM; Liu J; Cao YX; Zhang ZR
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2803-2808. PubMed ID: 31002131
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of tissue miR-338-3p predicts unfavorable prognosis of gastric cancer.
Liu S; Suo J; Wang C; Sun X; Wang D; He L; Zhang Y; Li W
Cancer Biomark; 2017 Dec; 21(1):117-122. PubMed ID: 29060930
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of miR-552 Predicts Unfavorable Prognosis of Gastric Cancer and Promotes the Proliferation, Migration, and Invasion of Gastric Cancer Cells.
Feng X; Zhu M; Liao B; Tian T; Li M; Wang Z; Chen G
Oncol Res Treat; 2020; 43(3):103-111. PubMed ID: 31958799
[TBL] [Abstract][Full Text] [Related]
12. Dysregulation of miR-126/Crk protein axis predicts poor prognosis in gastric cancer patients.
Feng R; Sah BK; Beeharry MK; Yuan F; Su L; Jin X; Yan M; Liu B; Li C; Zhu Z
Cancer Biomark; 2018 Feb; 21(2):335-343. PubMed ID: 29171987
[TBL] [Abstract][Full Text] [Related]
13. MiR-1236-3p serves as a new diagnostic and prognostic biomarker for gastric cancer.
An JX; Ma ZS; Ma MH; Shao S; Cao FL; Dai DQ
Cancer Biomark; 2019; 25(2):127-132. PubMed ID: 31045511
[TBL] [Abstract][Full Text] [Related]
14. Reduced miR-490-3p expression is associated with poor prognosis of Helicobacter pylori induced gastric cancer.
Qu M; Li L; Zheng WC
Eur Rev Med Pharmacol Sci; 2017 Aug; 21(15):3384-3388. PubMed ID: 28829504
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
Kong Y; Ning L; Qiu F; Yu Q; Cao B
Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
[TBL] [Abstract][Full Text] [Related]
16. High expression of miR-16 and miR-451 predicating better prognosis in patients with gastric cancer.
Ren C; Chen H; Han C; Fu D; Wang D; Shen M
J Cancer Res Clin Oncol; 2016 Dec; 142(12):2489-2496. PubMed ID: 27605261
[TBL] [Abstract][Full Text] [Related]
17. Decreased miR-198 expression and its prognostic significance in human gastric cancer.
Cui Z; Zheng X; Kong D
World J Surg Oncol; 2016 Feb; 14():33. PubMed ID: 26852230
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of candidate microRNAs in gastric cancer: A validation study.
Zhang L; Huang Z; Zhang H; Zhu M; Zhu W; Zhou X; Liu P
Cancer Biomark; 2017; 18(3):221-230. PubMed ID: 27983528
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer.
Ma G; Dai W; Sang A; Yang X; Gao C
Int J Clin Exp Pathol; 2014; 7(12):8833-40. PubMed ID: 25674252
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of microRNA-126 and microRNA-133b acts as novel predictor biomarkers in progression and metastasis of non small cell lung cancer.
Chen SW; Wang TB; Tian YH; Zheng YG
Int J Clin Exp Pathol; 2015; 8(11):14983-8. PubMed ID: 26823832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]